Skip to main content

David Budd

Epistem has appointed David Budd as CEO and a director of the company. He will join Epistem by the middle of April 2016. Budd joins Epistem from Leica Biosystems Amsterdam where he served as general manager. Previously, he served as commercial director at Leica Biosystems Newcastle. Prior to his work at Leica systems, he served as director of marketing at Siemens Healthcare Diagnostics, business unit leader at Bayer Diagnostics, and Sales Manager at Visible Genetics.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.